Last reviewed · How we verify
NCT05489094
The Impact of Nutrition Education and Milk Provision in Fueling the Progress of 1 - 3 Years Old Children
Phase 4 trial testing Nutrition Education and Growing Up Milk for 1 - 3 years old in Iron-deficiency in 196 participants. Status unknown.
28 February 2023
Quick facts
| Lead sponsor | Danone Specialized Nutrition Indonesia |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 196 |
| Start date | 31 August 2022 |
| Primary completion | 28 February 2023 |
| Estimated completion | 28 February 2023 |
Drugs / interventions tested
- Nutrition Education and Growing Up Milk for 1 - 3 years old
- Nutrition Education
Conditions studied
- Iron-deficiency — all drugs for Iron-deficiency →
Sponsor
Danone Specialized Nutrition Indonesia
Who can join
Adults 12 Months to 32 Months, any sex, with Iron-deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will be conducted by the Indonesia Nutrition Association that led by a Principle Investigator and supported by the study team consisted of Nutritionists. The aims of the study are to reduce iron deficiency by increasing iron intake in children 1-3 years by providing interventions in the form of increasing iron intake from growing up milk for four months and nutrition education for the intervention group and nutrition education only for the control group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05489094
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Iron-deficiency
Currently open trials in the same condition.
- NCT05407987 — Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) · Phase 3 · recruiting
- NCT06270498 — Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure · Phase 4 · recruiting
- NCT05913414 — Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT05340465 — Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants · Phase 2 · recruiting
- NCT07083492 — Non-invasive Detection of Iron Deficiency in Obstetrics · recruiting
Other Danone Specialized Nutrition Indonesia trials
Trials by the same sponsor.
- NCT06204770 — Tolerance of Extensive Hydrolyzed Whey Protein Milk Among Infant With Mild to Moderate CMPA · Phase 4 · terminated
- NCT05393934 — Growth Faltering Intervention Using Pediatric Nutritional Care (PNC) vs.PNC& FSMP · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05489094 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Danone Specialized Nutrition Indonesia
- Last refreshed: 15 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05489094.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing